The Massachusetts General Hospital Infectious Diseases Division has offered standard-setting, innovative, and comprehensive care for our patients since 1956. Through the leadership of our chief, Rochelle Walensky, MD, MPH, we offer a wide range of inpatient and outpatient clinical services related to the care of patients with infectious diseases. Our physicians conduct a broad array of both basic and clinical research activities in a variety of areas of microbiology, molecular biology, immunology and host defense.

One of the core goals of our division is offering unparalleled opportunities in clinical and research training in Infectious Diseases. Through our diverse faculty interests and partnerships with Brigham and Women’s Hospital, the Ragon Institute, the Massachusetts Institute of Technology, and more, we avidly promote and mentor our fellows’ research interests. We view the training of future teachers and investigators as our most enduring contribution to medical science.

The Infectious Diseases Division offers clinical care for all major areas of infectious diseases. We strive to provide care that is comprehensive and timely with early and well-coordinated transition to outpatient care. Our board-certified specialists offer extensive and compassionate care to diagnose and manage both common and complex diseases including:

The Infectious Diseases Division at Mass General is a leader in the research of infectious diseases and is committed to developing global collaboration in the efforts to study and deliver and diagnose disease worldwide. Research in the Infectious Diseases Division focuses on the molecular pathogenesis of bacterial and fungal infection; regulation of virulence gene expression in pathogens in response to environmental and in vivo signals; international collaborative studies in Bangladesh on cholera, dengue, cryptosporidium and typhoid fever; the development of live, attenuated, mucosal vaccines and vaccine vectors; the mechanisms of action of endotoxin; the mechanisms of bacterial resistance to antimicrobial agents; development of novel classes of antimicrobial agents; pathogenesis and immune responses to hepatitis C virus infection; pathogenesis of CMV infection; human genetic susceptibility to infectious diseases; epidemiology, outcomes research, and health policy; adherence and HIV treatment outcomes; and studies on infections related to transplantation and other immunocompromising disorders. Through our close affiliation with the Ragon Institute, research focuses on the immunopathogenesis of HIV infection, and on pharmacologic and immunotherapeutic interventions targeted at HIV.

Part of our mission at Mass General is to not only provide state of the art clinical care, but also to offer you the opportunity to participate in clinical research trials. 

Back to Top